Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03751436
Recruitment Status : Recruiting
First Posted : November 23, 2018
Last Update Posted : February 13, 2020
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Roswell Park Cancer Institute

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 7, 2022
Estimated Study Completion Date : June 7, 2023